Results 11 to 20 of about 459,163 (313)
A Cautionary Tale of Triple Therapy
JACC: Case Reports, 2021 A 54-year-old man with a history of atrial flutter presented with anterior ST-segment elevation myocardial infarction complicated by cardiogenic shock and underwent percutaneous coronary intervention of the left main coronary artery. He was placed on triple antithrombotic therapy and ultimately recovered.
Shahandeh, Negeen +3 more
openaire +5 more sources
Isobologram analysis of triple therapies [PDF]
Radiation Oncology, 2006 New concepts in radiation oncology are based on the concept that combinations of irradiation and molecular targeted drugs can yield synergistic or at least additive effects. Up to now the combination of two treatment modalities has been tested in almost all cases.
Belka Claus, Niyazi Maximilian
openaire +3 more sources
Triple Therapy vs Triple Therapy in COPD
Archivos de Bronconeumología (English Edition), 2017 Peer ...
López-Campos, J. L. +2 more
openaire +3 more sources
The Triple Challenge of Triple Therapy
JACC: Cardiovascular Interventions, 2016 The addition of dual antiplatelet (DAPT) therapy to oral anticoagulant triples the risk of major bleeding complications [(1–4)][1]. Patients who are exposed to triple therapy should be considered at high risk for bleeding given the fact that, in addition to the risk of triple therapy itself ...
Jean-Philippe, Collet +2 more
openaire +2 more sources
COPD, 2022 Triple therapy for chronic obstructive pulmonary disease (COPD) is recommended for some patients, but the inhaled corticosteroids (ICS) may differ in effectiveness and safety. We compared budesonide-based and fluticasone-based triple therapy given in two
Samy Suissa +2 more
doaj +1 more source
Frontiers in Oncology, 2022 BackgroundEarly recurrence is common after surgical resection (SR) for hepatocellular carcinoma (HCC) with high risk of recurrence and is associated with poor prognosis.
Jun-Yi Wu +15 more
doaj +1 more source
Co-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse models. [PDF]
, 2017 Metastasis is a major cause of mortality for cancer patients and remains as the greatest challenge in cancer therapy. Driven by multiple factors, metastasis may not be controlled by the inhibition of single target.
DeVere White, Ralph W +11 more
core +1 more source
Cost-utility of triple versus dual inhaler therapy in moderate to severe asthma
BMC Pulmonary Medicine, 2021 Background An important proportion of asthma patients remain uncontrolled despite using inhaled corticosteroids and long-acting beta-agonists. Clinical guidelines recommend, in these patients, using add-on long-acting muscarinic antagonists (triple ...
Jefferson Antonio Buendía +1 more
doaj +1 more source
Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Cote d\u27Ivoire [PDF]
, 2019 BackgroundA single co-administered dose of ivermectin (IVM) plus diethylcarbamazine (DEC) plus albendazole (ALB), or triple-drug therapy, was recently found to be more effective for clearing microfilariae (Mf) than standard DEC plus ALB currently used ...
Bjerum, Catherine M +9 more
core +4 more sources
Frontiers in Pharmacology, 2022 Background: Cystic fibrosis is a rare, recessive, progressive genetic disease caused by dysfunction of the cystic fibrosis transmembrane conductance regulator (CFTR) protein.
Yizi Wang, Bin Ma, Wenya Li, Peiwen Li
doaj +1 more source